文献速递脑血管病外科功能神经外科

脑动静脉畸形放射外科治疗后的癫痫结局:更新系统评价与Meta分析

Seizure Outcomes After Radiosurgery for Cerebral Arteriovenous Malformations: An Updated Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2018-08-24

该系统评价与Meta分析检索1987年1月至2018年1月PubMed和MEDLINE数据库,纳入27项研究、4826例患者,评估立体定向放射外科(SRS)治疗脑动静脉畸形(AVM)相关癫痫的发作控制率及预测因素。结果显示SRS可使多数患者获得癫痫控制,畸形血管团闭塞与癫痫无发作显著相关。

要点

  • 4826例AVM患者中1456例(34.7% [26.0-43.9%])发生一次或以上癫痫发作,平均随访48±7个月。
  • 1312例中910例(73.1% [66.9-78.9%])获得癫痫控制,1245例中597例(55.7% [44.5-66.6%])达到癫痫无发作。
  • 259例癫痫无发作患者中175例(67.3% [46.3-85.1%])成功停用抗癫痫药物。

核心结论

  • SRS可使多数AVM相关癫痫患者获得癫痫控制,约三分之二的癫痫无发作患者能够停用抗癫痫药物。
  • 畸形血管团闭塞似乎提高癫痫无发作的可能性,因此仍是SRS干预的主要目标。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed和MEDLINE数据库1987年1月至2018年1月文献,遵循PRISMA指南。
  • 纳入报告SRS后结局数据且AVM相关癫痫患者≥5例的研究,共纳入27项研究、4826例患者。

主要发现

  • 4826例患者中1456例(34.7% [26.0-43.9%])发生一次或以上癫痫发作,平均随访48±7个月。
  • 1312例中910例(73.1% [66.9-78.9%])获得癫痫控制(癫痫无发作或发作改善)。
  • 1245例中597例(55.7% [44.5-66.6%])达到癫痫无发作。
  • 259例癫痫无发作患者中175例(67.3% [46.3-85.1%])成功停用抗癫痫药物。

关键数值与推荐

  • AVM闭塞与癫痫无发作显著相关(OR 4.61;P < 0.001)。
  • 较短癫痫病程与癫痫无发作显著相关(OR 6.80;P < 0.001)。
  • 全身性发作类型与癫痫无发作显著相关(OR 2.27;P = 0.007)。
  • 既往AVM出血与癫痫无发作显著相关(OR 5.10;P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The seizure outcomes for patients with brain arteriovenous malformations (AVM) who undergo intervention with stereotactic radiosurgery (SRS) are incompletely understood. We sought to determine, in a systematic review and meta-analysis, the rates of seizure control after SRS for patients with AVM-associated seizures and identify predictive factors. METHODS: We performed a systematic review of PubMed and MEDLINE databases from January 1987 to January 2018, in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting post-SRS outcomes data for ≥5 patients with AVM-associated seizures were included. The seizure outcomes and factors associated with seizure freedom were evaluated using meta-analysis. RESULTS: A total of 27 studies, comprising 4826 patients, met the inclusion criteria for analysis. One or more seizures occurred in 1456 of 4826 patients (34.7% [26.0-43.9%]), and the mean follow-up was 48 ± 7 months. Seizure control (seizure freedom or seizure improvement) was achieved in 910 of 1312 patients (73.1% [66.9-78.9%]). Seizure freedom was achieved in 597 of 1245 patients (55.7% [44.5-66.6%]). Of 259 patients with seizure freedom, cessation of antiepileptic drugs was achieved in 175 patients (67.3% [46.3-85.1%]). AVM obliteration (odds ratio [OR] 4.61; P < 0.001), shorter seizure duration (OR 6.80; P < 0.001), generalized seizure type (OR 2.27; P = 0.007), and previous AVM hemorrhage (OR 5.10; P < 0.001) were significantly associated with seizure freedom. CONCLUSIONS: SRS affords seizure control to the majority of patients with AVM-associated seizures, and approximately two thirds of those with seizure freedom are able cease anticonvulsants. Nidal obliteration appears to improve the likelihood of seizure freedom, and thus remains the primary goal of intervention with SRS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ironside N, Chen CJ, Ding D, et al. Seizure Outcomes After Radiosurgery for Cerebral Arteriovenous Malformations: An Updated Systematic Review and Meta-Analysis. World Neurosurg. 2018. PMID: 30149174. doi:10.1016/j.wneu.2018.08.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。